Individuals at the genetic risk of AD carrying E4 variant of apolipoprotein E (APOE4) showed increased activity of the matrix metalloproteinase (MMP)-9 which induces BBB disruption [76]. This evidence concerns the gene APOE and Alzheimer disease.